Bio-Shield 2019-nCoV IgM

Bio-Shield 2019-nCoV IgM Immunoglobulins, is a semi-quantitative ELISA test for the determination of IgM against SARS-CoV-2 in human serum or plasma (Heparin, EDTA or Citrate) specimens.

Bio-Shield 2019-nCoV IgM

Specifications

ELISA KIT CHARACTERISTICS:

■ Semi-quantitative ELISA test with single-break strip plate with 48 wells (6 strips) or 96 wells (12 strips)

■ Clinical Diagnostic Sensitivity 82.66%, 62/75 (CI: 0.7257 to 0.8958), Clinical Diagnostic Specificity 100%, 91/91 (CI: 0.9595 to 1)

■ Ιnternal validation results: 92.31%, 72/78 (CI: 0.8422 to 0.9643) sensitivity & 99.85%, 666/667 (CI: 0.9916 to 0.9997) specificity

■ Test time: 90 min

■ Compatible with automated ELISA systems

■ Shelf Life: 12 months | Storage 2-8 °C

■ The test has received the CE-IVD mark and therefore is approved for diagnostic use in the E.U.

Product Manual

This content is for registered users only. Please login

Flyers & Catalog

PRODUCT CATALOG

Download

FLYERS

Download